郑州大学学报(医学版)
鄭州大學學報(醫學版)
정주대학학보(의학판)
JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES)
2015年
1期
124-127
,共4页
2型糖尿病%骨密度%糖化血红蛋白%血糖控制
2型糖尿病%骨密度%糖化血紅蛋白%血糖控製
2형당뇨병%골밀도%당화혈홍단백%혈당공제
type 2 diabetes mellitus%osteoporosis%bone mineral density%HbA1c%glycemic control
目的:探讨2型糖尿病(T2DM)患者血糖控制水平对骨密度的影响。方法:纳入T2DM患者170例,其中绝经前女性T2DM患者(A1组)21例,绝经后女性T2DM患者(A2组)79例,小于50岁男性T2DM患者(B1组)22例,50岁及以上男性T2DM患者( B2组)48例。应用双能X线骨密度仪测定所有患者腰椎( L2、L3、L4和L2~4)及股骨近端[(股骨颈( FN)、大转子( TM)和Wards三角区( WA)]的骨密度。以各部位骨密度为因变量,以糖化血红蛋白( HbA1c)、年龄、体重指数、病程等可能影响骨密度的因素为自变量,建立多重线性回归模型,分析血糖控制水平是否对T2DM患者骨密度有影响。结果:A1组未发现HbA1c水平对骨密度有影响。 A2组中HbA1c水平对L2、L3、L4和L2~4的骨密度有影响(β=-0.579、-0.556、-0.614和-0.476,P均<0.05)。 B1组中HbA1c水平对L4、L2~4和WA的骨密度有影响(β=-0.443、-0.284和-0.227,P均<0.05)。 B2组中HbA1c水平对L4、L2~4和TM的骨密度有影响(β=-0.745、-0.297和-0.147,P均<0.05)。结论:T2DM患者血糖控制水平是骨密度的影响因素,尤其是对于男性及绝经后女性患者。
目的:探討2型糖尿病(T2DM)患者血糖控製水平對骨密度的影響。方法:納入T2DM患者170例,其中絕經前女性T2DM患者(A1組)21例,絕經後女性T2DM患者(A2組)79例,小于50歲男性T2DM患者(B1組)22例,50歲及以上男性T2DM患者( B2組)48例。應用雙能X線骨密度儀測定所有患者腰椎( L2、L3、L4和L2~4)及股骨近耑[(股骨頸( FN)、大轉子( TM)和Wards三角區( WA)]的骨密度。以各部位骨密度為因變量,以糖化血紅蛋白( HbA1c)、年齡、體重指數、病程等可能影響骨密度的因素為自變量,建立多重線性迴歸模型,分析血糖控製水平是否對T2DM患者骨密度有影響。結果:A1組未髮現HbA1c水平對骨密度有影響。 A2組中HbA1c水平對L2、L3、L4和L2~4的骨密度有影響(β=-0.579、-0.556、-0.614和-0.476,P均<0.05)。 B1組中HbA1c水平對L4、L2~4和WA的骨密度有影響(β=-0.443、-0.284和-0.227,P均<0.05)。 B2組中HbA1c水平對L4、L2~4和TM的骨密度有影響(β=-0.745、-0.297和-0.147,P均<0.05)。結論:T2DM患者血糖控製水平是骨密度的影響因素,尤其是對于男性及絕經後女性患者。
목적:탐토2형당뇨병(T2DM)환자혈당공제수평대골밀도적영향。방법:납입T2DM환자170례,기중절경전녀성T2DM환자(A1조)21례,절경후녀성T2DM환자(A2조)79례,소우50세남성T2DM환자(B1조)22례,50세급이상남성T2DM환자( B2조)48례。응용쌍능X선골밀도의측정소유환자요추( L2、L3、L4화L2~4)급고골근단[(고골경( FN)、대전자( TM)화Wards삼각구( WA)]적골밀도。이각부위골밀도위인변량,이당화혈홍단백( HbA1c)、년령、체중지수、병정등가능영향골밀도적인소위자변량,건립다중선성회귀모형,분석혈당공제수평시부대T2DM환자골밀도유영향。결과:A1조미발현HbA1c수평대골밀도유영향。 A2조중HbA1c수평대L2、L3、L4화L2~4적골밀도유영향(β=-0.579、-0.556、-0.614화-0.476,P균<0.05)。 B1조중HbA1c수평대L4、L2~4화WA적골밀도유영향(β=-0.443、-0.284화-0.227,P균<0.05)。 B2조중HbA1c수평대L4、L2~4화TM적골밀도유영향(β=-0.745、-0.297화-0.147,P균<0.05)。결론:T2DM환자혈당공제수평시골밀도적영향인소,우기시대우남성급절경후녀성환자。
Aim:To evaluate the effects of glycemic control station on bone mineral density (BMD) in patients with type 2 diabetes mellitus(T2DM).Methods:A total of 170 patients with T2DM were enrolled in the study.These patients included premenopausal female patients (group A1,21 cases), postmenopausal female patients (group A2,79 cases), male patients less than 50 years old (group B1,22 cases) and male patients of 50 years old or older(group B2,48 cases). BMD of lumbar vertebra (L2, L3, L4, L2-4) and hip [femoral neck(FN), trochanter major(TM) and wards area(WA)] were detected by dual energy X-ray absorptiometry.Glycosylated hemoglobin A1c (HbA1c) was detected by high perform-ance liquid chromatography method .Multiple regression analysis was employed with HbA 1c, BMI, age and duration as in- dependent variants and BMD as the dependence variant .Results:There were no significant correlations between BMD and HbA1c in group A1.However, BMD of L2 , L3 , L4 and L2-4 in group A2(β=-0.579,-0.556,-0.614 and -0.476, P<0.05), BMD of L4, L2-4 and WA in group B1(β=-0.443,-0.284 and -0.227,P<0.05) and that of L4, L2-4 and TM in group B2(β=-0.745,-0.297 and -0.147,P<0.05) were affected by HbA1c.Conclusion:Glycemic con-trol station could affect the maintainance of BMD in male and postmenopausal female patients with T 2DM.